The uterus was atrophic, no significant masses were palpable in ... (3) Cervical adenosquamous carcinoma: A rare malignant epithelial neoplasm of the cervix that contains clearly identifiable ...
Identify the anterior and posterior lip of the cervix, red columnar epithelium, pink squamous epithelium, the squamocolumnar junction, and the transformation zone. Observe all four vaginal ...
We studied altogether 50 samples representing human cervical disease of different grades, together with four samples representing normal squamous epithelium and two from columnar cervical epithelium.
Department of Gynecological Oncology, Hunan Cancer Hospital/the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, P.R. China. *Corresponding Author: ...
(NASDAQ: PBYI), a biopharmaceutical company, announced that the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology (NCCN Guidelines ®) for Cervical Cancer were ...
1 Xiang L, Jiang W, Ye S, He T, Pei X, Li J, et al. ERBB2 mutation: A promising target in non-squamous cervical cancer. Gynecol Oncol. 2018;148(2):311-316. 2 Zammataro L, Lopez S, Bellone S ...
Please see Full Prescribing Information for additional safety information. 1 Xiang L, Jiang W, Ye S, He T, Pei X, Li J, et al. ERBB2 mutation: A promising target in non-squamous cervical cancer.